EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY-NC 4.0

Free antiretrovirals as a key tool against the HIV pandemic: A systematic review

Melissa Doutre, Marie-Pier Godin, Iliya Dmitriev, Ana Paula Pena-Gralle, Amy Bergeron iD, Lucie Blais, Benoît Lemire iD

HIV Medicine · 2025

DOI: 10.1111/hiv.70051 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift HIV Medicine, 2025. Verfasst von Melissa Doutre und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: HIV Infections, Anti-Retroviral Agents, Anti-HIV Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives Access to antiretroviral (ARV) drugs remains a critical challenge in achieving the WHO/UNAIDS 95‐95‐95 targets, with medication costs representing a substantial barrier. This systematic review evaluates the effect of free ARVs, without out‐of‐pocket cost to the patient, on the HIV cascade of care: the use of ARV therapy, viral suppression and the use of prophylaxis (PrEP).

Methods

The following databases were searched for publications between 1 January 1996 and 10 July 2024: MEDLINE, Embase, CINAHL, CNKI, Global Index Medicus, the Web of Science, the SciELO Citation Index and grey literature. Publications were eligible if they included people living with or at risk of HIV and compared free access to ARVs with out‐of‐pocket fees. Reviewers screened publications that focused on the outcomes: being on therapy, being virally suppressed and being on PrEP. The National Heart, Lung and Blood Institute (NHLBI) and Joanna Briggs Institute (JBI) Quality Assessment Tools were used to assess publication quality.

Results

A total of 34164 documents were identified, and 407 full‐text manuscripts were reviewed. A total of 22 publications met the inclusion criteria. In six of the seven publications reporting on being on therapy, providing free ARVs increased the number of people who received treatment. All four publications reporting on viral suppression showed improvement with free access. Additionally, both publications reporting on PrEP use showed increased utilization with free access.

Conclusions

The review offers valuable insights for countries considering implementing free ARV programmes. It suggests that expanding access to free ARVs helps achieve the global HIV targets and improve health outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-Retroviral AgentsAnti-HIV AgentsHumansPandemicsHealth Services AccessibilityPre-Exposure Prophylaxis

Stichwörter der Autor:innen

95‐95‐95 targetsHIVantiretroviral therapycost‐sharingpre‐exposure prophylaxissystematic review

Substanzen

Anti-Retroviral AgentsAnti-HIV Agents

Autor:innen und Institutionen

  • Faculty of Pharmacy, University of Montreal, Montreal, Quebec, Canada.
  • Pharmacy Department, McGill University Health Centre, Montreal, Quebec, Canada.
  • Faculty of Medicine, University of Montreal, Montreal, Quebec, Canada.
  • Health Library, University of Montreal, Montreal, Quebec, Canada.

ORCID-Profile: Amy Bergeron, Benoît Lemire

Zitieren

APA

Doutre, M., Godin, M. P., Dmitriev, I., Pena-Gralle, A. P., Bergeron, A., Blais, L., & Lemire, B. (2025). Free antiretrovirals as a key tool against the HIV pandemic: A systematic review. HIV Medicine. https://doi.org/10.1111/hiv.70051

Vancouver

Doutre M, Godin MP, Dmitriev I, Pena-Gralle AP, Bergeron A, Blais L, et al. Free antiretrovirals as a key tool against the HIV pandemic: A systematic review. HIV Medicine. 2025. doi:10.1111/hiv.70051

BibTeX
@article{Doutre2025,
  author = {Doutre, Melissa and Godin, Marie-Pier and Dmitriev, Iliya and Pena-Gralle, Ana Paula and Bergeron, Amy and Blais, Lucie and Lemire, Benoît},
  title = {Free antiretrovirals as a key tool against the HIV pandemic: A systematic review},
  journal = {HIV Medicine},
  year = {2025},
  doi = {10.1111/hiv.70051}
}
Kostenlos starten →